Publicaciones en colaboración con investigadores/as de University of Texas Health Science Center at San Antonio (3)

2014

  1. Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 111, Núm. 24, pp. 8838-8843